Engineering Novel Diagnostic Modalities and Implantable Cytomimetic Nanomaterials for Next-Generation Medicine  by Ho, Dean et al.
E
I
N
I
N
T
a
u
ﬁ
F
Biology of Blood and Marrow Transplantation 12:92-99 (2006)
 2006 American Society for Blood and Marrow Transplantation
1083-8791/06/1201-0117$32.00/0
doi:10.1016/j.bbmt.2005.09.013
9ngineering Novel Diagnostic Modalities and
mplantable Cytomimetic Nanomaterials for
ext-Generation Medicine
Dean Ho, Andrew O. Fung, Carlo D. Montemagno
Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of
California at Los Angeles, Los Angeles, California
Correspondence and reprint requests: Dean Ho, PhD, and Carlo D. Montemagno, PhD, Department of
Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California at Los
Angeles, 7523 Boelter Hall, 420 Westwood Plaza, Los Angeles, CA 90095 (e-mail: deanh@seas.ucla.edu and
cdm@seas.ucla.edu)
ABSTRACT
The advent of 21st century medicine will be based on a comprehensive approach to achieving the highly
sensitive and specific detection of diseases, as well as the development of novel materials and devices based on
biotic-abiotic interfacing as interventional modalities. Novel technologies that enable early identification of
physiological changes will serve as a gateway tool for the proper treatment of these disorders. Toward the
realization of these technologies, microfabrication and nanofabrication methods have been applied to biomed-
ical systems that allow scientists to interact with cellular and molecular systems on their native size scales.
Future enabling systems will build on the foundation composed of such devices. With respect to the envisioned
fruition of biofunctional nanomaterials and systems, foundational studies of biological systems and molecules,
as well as their interfacing with biocompatible materials, have produced a domain of components that can be
integrated and engineered toward eventual cytomimetic materials for transplantation. In addition, the potential
underscoring of their future applications in nanoscale medicine is based on the ability to engineer and design
intelligent membrane/protein self-assembling and organization phenomena that are typically found in nature
into these artificial composite systems. These devices will provide a powerful suite of solutions with broad
applicabilities in nanomedicine, for example, (1) the use of concomitant protein functionality toward energy
production and the powering of medical implants and (2) replacement of damaged cells (e.g., heart and neuron)
with implantable biologically intelligent engineered materials. This work will examine key advances in the
areas of diagnostics and synthetic biology that have led to visionary contributions to next-generation medicine.
Furthermore, we present 2 devices that will contribute to the realization of compelling biosensing and
biofunctional material technologies. These systems include advanced diagnostic platforms for whole-cell
detection, as well as copolymeric materials that have been functionalized by the coupled activity of their
embedded membrane proteins. They are envisioned to successfully bridge the gap between foundational
scientific progress and the realization of rapid point-of-care disease assessment and biofunctional devices with
higher-order behavior.
© 2006 American Society for Blood and Marrow Transplantation
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iNTRODUCTION
ext-Generation Medicine: Diagnostics and
herapeutic Nanomaterials
Advancements in bionanoscience have contributed
n all-inclusive collection of fundamental information
pon which the technological translation of these
ndings beneﬁts the next generation of medical tools.
or example, microfabrication technology enables n
2ystems to be engineered with structures and devices
n the size scale of a single cell. As such, cellular
nteractions can be directed and engineered with the
ncorporation of microfabrication technology into
iomedical systems. The ability to harness whole cells
nd active biological molecules as engineering tools
ealizes novel diagnostic capabilities for ex vivo med-
cine that are founded on the mechanisms by which
ature manipulates matter and information. Addition-
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Blly, the ability to mimic biological processes at the
anoscale will enable the engineering of functional
anomaterials for implantable replacement therapeu-
ics for damaged cells or cell membranes associated
ith cardiac and neuronal abnormalities.
ortable Diagnostics for Physiological Fluids
The analysis of physiological ﬂuids for indications
f the in vivo health state has been a long-sought and
ost desirable goal in health care. The possibility to
onitor the progression of health and disease in a
edium outside the body holds signiﬁcant potential
or informative, readily available diagnostics. There-
ore, a fundamental improvement in popular medicine
waits behind each achievement that is made toward
his goal. However, two prerequisites exist for the
ealization of such effective medical technologies:
nowledge of a speciﬁc biomarker or cellular state that
orrelates with a disease state and technology that
iscerns healthy from diseased specimens. Where
hese medical and technological conditions converge,
he potential beneﬁts to medicine are deep and far-
eaching.
Enabled by innovative applications of microfabri-
ation and novel nanoengineering tools, scientists are
ble to manipulate biological systems with previously
nattainable dexterity and resolution. The following
ection presents some emerging technologies for mi-
roscale handling of cells in the detection of disease in
ody ﬂuids. Indeed, the state of the art is moving in a
eneral trend toward integrated implementations of
ample conditioning, analyte detection, and analysis,
.e., the lab on a chip [1]. To this end, microﬂuidics is
n enabling technology that has the potential to deﬁne
he next-generation biological assay. The shrinking of
onventional laboratory processes can result in assays
hat accommodate smaller reagent volumes, shorter
rocessing times, and multiplexed sample analysis in a
ompact platform. Future medicine thus seeks to
ring the laboratory to the patient in the form of
oint-of-care and household diagnostics. In addition
o the usual advantages of miniaturization, microﬂu-
dic technology exploits physical phenomena particu-
ar to the microscale, such as laminar ﬂow, diffusion-
riven mass transport, a high surface area–volume
atio, and high-density energy ﬁelds. Examples of such
evices have been realized to isolate subpopulations of
lood cells.
Each microliter of normal blood contains a heter-
geneous mixture of approximately 5 million cells. As
lood circulates through the body, the cells continu-
usly adapt to physiological conditions. Therefore,
mportant information can be extracted from a given
roﬁle of cellular characteristics. One approach uses
he control of ﬂow in microenvironments to distin-
uish cells on the basis of their mechanical properties. r
B&MTor example, healthy red blood cells (RBCs) ﬁt
hrough narrow capillaries because of their ﬂexible
iconcave disc form. Certain diseases, such as malaria,
ncrease the membrane stiffness of erythrocytes. Med-
cal complications occur when infected cells become
aught in circulatory passages. This effect has been
imulated by a series of 2- to 6-m microfabricated
apillary vessels that effectively separated rigid, in-
ected RBCs from normal cells [2]. Infected cells ac-
umulate at the entrance to narrow channels as a
esult of their abnormal rigidity. Healthy cells are still
ble to squeeze through the blockage and pass into the
arrow channel. The behavior of particles in laminar
ow also lends to size separation in ﬂuid streams. A
tudy using shear-driven ﬂow over microsteps was
erformed in polymer microchannels [3]. The partic-
lar ﬂuid dynamics of this system generated a slight
ackward ﬂow that kept larger cells from clogging the
hannel and concentrated them in narrow bands near
he step. Thus, the cells in a mixture were size-frac-
ionated with the preservation of their structural in-
egrity. The separation device was demonstrated by
sing bacteria and yeast particles, although the prin-
iple could be applied to stem cells and leukocytes.
Dielectrophoresis (DEP) manipulates cells by us-
ng the interactions between their intrinsic dielectric
olarization and a nonuniform applied electric ﬁeld.
he exact polarization of the cell reﬂects such char-
cteristics as the internal structure, membrane struc-
ure, and size of the nucleus [4]. Electric ﬁelds scale
own advantageously, and low voltages are sufﬁcient
o create controlled, concentrated ﬁelds at the mi-
roscale. Systems have been realized that use DEP to
rap, translate, and separate cells. One such instance
sed an asymmetric 3-dimensional electrode conﬁgu-
ation to exploit differences between the hydrody-
amic drag forces and the negative DEP forces expe-
ienced by a cell [5]. The study was able to separate
ouse stem cells and RBCs to purities of 81.5% and
4.1%, respectively. The device, fabricated in a Pyrex
hannel, is an example of technology that could lead to
igh-throughput cell separation and that is also non-
nvasive; i.e., it does not use animal antibody.
iology and Advanced Materials as Building Blocks
or Nanomedical Technology
Membrane proteins serve as the engines that drive
he processes of life, from bacteria to human beings.
n Halobacterium halobium, for example, a light-depen-
ent bacteriorhodopsin protein uses sunlight to gen-
rate proton gradients, which then induce the adeno-
ine triphosphate (ATP) synthase protein to produce
TP, the energy currency of the cell. As such, this
ooperative activity between proteins serves as a vital
rocess for organismal survival. In humans, membrane
roteins are largely responsible for driving both neu-
onal and cardiac cell functionality: the coordinated
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9pening and closing of membrane-bound channels
egulate sodium, potassium, calcium, and chloride ion
ransport for action potential generation. In addition,
ater-transporting aquaporin proteins facilitate water
iffusion in the urinary system.
Structural and mechanistic studies of these pro-
eins have provided the fundamental framework of
nderstanding how they function through the eluci-
ation of the conformational and other operational
arameters that govern their activity. Because they are
embrane proteins, conventional lipid-based systems
ave typically been used as the reconstitution matrix
or reacquisition of the 3-dimensional structures nec-
ssary for protein function [6]. Although these protein-
ipid contructs have been a vital part in basic science
tudies, their lack of stability and robustness has led to
he introduction of a novel class of biocompatible mate-
ials that can harness protein activity. Initially adapted to
he “black lipid membrane” suspended membrane pro-
ocol, ABA triblock copolymer–based membranes com-
osed of polymethyloxazoline (PMOXA)-polydimethyl-
iloxane-PMOXA were smeared across Teﬂon septa
Eastern Scientiﬁc LLC, Rockville, MD), and electric
eld–induced irreversible rupture trials were con-
ucted to characterize ﬁlm robustness [7,8]. These
tudies demonstrated that copolymer ﬁlms possess
ramatically higher irreversible rupture voltages (ap-
roximately 1.5 V) than those found in lipid systems
approximately 500 mV). In addition, Langmuir com-
ression isotherm testing has revealed that copolymer
embranes can exhibit higher collapse pressures than
ipid systems, and this also signiﬁed a higher mechan-
cal stability in the copolymers.
After the successful demonstration of single-mol-
cule-thick triblock membranes, the measurement of
rotein functionality in these copolymers made the
se of proteins as the core component of biologically
ctive devices a feasible prospect [9,10]. Additionally,
he introduction of a wide variety of diblock and
riblock copolymers with the ability to self-assemble
nto various shapes (including tubes, spheres, and lam-
nae), as well as the demonstrated fusion and intelli-
ent interaction between these structures, has shown
hat properties inherent to nature can be engineered
nto artiﬁcial systems [11]. For example, a fundamen-
al piece of work ﬁrst demonstrated that diverse mor-
hologic characteristics could be attained from iden-
ically composed linear block copolymer chains that
aried only by block lengths. Zhang and Eisenberg
11] reported an unprecedented number of morpho-
ogic characteristics that could be obtained with a
olystyrene–polyacrylic acid diblock copolymer. Spe-
iﬁcally, 6 different shapes were obtained, including
pheres, rods, lamellae, vesicles, micelle-like aggre-
ates, and microscale spheres with hydrophilic sur-
aces and enclosed micelle-like aggregates. In addi-
ion, when aqueous solutions of the spherical micelles
4ere dried, a needle-like structure could be obtained.
y manipulation of the asymmetry between the poly-
tyrene–polyacrylic acid blocks, shape changes could
e induced. For example, the most symmetrical struc-
ure, deﬁned as 200-b-21 (polystyrene-polyacrylic acid
PS-b-PAA]), formed spherical micelles. When the
AA block was decreased (200-b-15), the morphology
hanged from spherical to rod-shaped. With use of a
00-b-8 complex, vesicular objects that resembled hol-
ow spheres were observed instead of rods. Through
hese studies, it could be clearly seen that copolymeric
aterials play a dual role: they preserve protein activ-
ty and posses intelligent self-assembling behavior that
ill contribute to their eventual cytomimetic/biomi-
etic applications.
The collection of biological building blocks that
ave been made available to the synthetic biology
ommunity through these fundamental breakthroughs
ill ultimately lead to the generation of intelligent
tructures for nanomedical applications. In fact, self-
ssembling structures have successfully served as cell-
argeting and drug-carrying agents for potential nano-
herapeutic development [12,13]. Furthermore,
riblock copolymers have also been shown to be effec-
ive sealants of cellular defects [14]. As such, recent
rogress has aimed to incorporate these components
nd their inherent properties toward the derivation of
timuli-induced higher-order behavior, much like the
esultant properties of embedded intelligence within
aturally occurring systems.
URRENT RESULTS AND DISCUSSION
dvances in Biodetection
Microﬂuidic devices are also being explored for
uids other than blood. In recent years, saliva has been
ncreasingly regarded for its potential as a diagnostic
uid. The exchange of informative analytes between
lood and saliva makes the latter a virtual mirror of
he body. A wide range of health and disease states are
eﬂected in the salivary content of hormones, immu-
ologic biomarkers, metabolic products, and drugs
15,16]. Furthermore, because saliva comes into inti-
ate contact with the bacterial ﬂora of the mouth, it
s the natural choice of a medium for oral health
iagnostics. Compared with serum, saliva is rela-
ively easy to collect, store, and ship. Successful
mplementation of saliva analysis in lab-on-a-chip
evices would open doors for inexpensive, noninva-
ive health monitoring. A primary hindrance to the
ealization of saliva diagnostics has been that most
nalytes of interest are found in smaller amounts in
aliva than in serum [17]. However, new highly
ensitive detection schemes are steadily overcoming
his limitation.In one example of molecular diagnosis for sys-
t
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Novel Diagnostic Modalities and Implantable Cytomimetic Nanomaterials
Bemic health, a microarrayed bead assay was developed
or the detection of salivary C-reactive protein, an
ndicator of cardiovascular disease [18]. In this system,
80-m agarose beads were coated with antibody and
ositioned in etched silicon wells, where they were
sed as the solid support for sandwich-type ﬂuores-
ent and colorimetric immunoassays. After a contin-
ous ﬂow assay, the optical signal was captured by a
harge-coupled device so that individual microspheres
ould be addressed in image analysis. C-reactive pro-
ein was detected in the range of 10 fg/mL to 10
g/mL.
Saliva can also be assayed for its content of peri-
dontal pathogens. The mouth is home to the body’s
ost diverse population of microbial ﬂora, and al-
hough many of these species reside harmlessly in the
ral cavity, researchers have implicated certain bacte-
ia in the initiation and proliferation of periodontal
isease. Therefore, it is expected that quantitative de-
ection of bacteria will gain importance in oral health
onitoring. Immunologic traits can be exploited to
iscern the harmful species. Provided that a suitable
ntibody is available, controlled immobilization of an-
ibody can be used to capture oral pathogens on the
asis of species-speciﬁc markers on the cell’s surface.
n such a scheme, medical scientists could identify a
arget pathogen and develop an antibody against the
pecies which is integrated into an on-chip immuno-
ssay. Consider, for example, Streptococcus mutans,
hich is implicated as the primary causative pathogen
f dental caries. Using hybridoma techniques, dental
esearchers developed a monoclonal anti–S. mutans
mmunoglobulin G [19] and demonstrated its utility in
he quantitative detection of bacteria in saliva. The
mmunoglobulin G was cross-linked to the surface of
DMS devices by aminosilane-glutaraldehyde cou-
ling [20] (Figure 1A). Atomic force microscope
AFM) scans clearly distinguished antibody-coated
urfaces from untreated PDMS (Figure 1B). The re-
ulting immunosensors were able to speciﬁcally cap-
ure S. mutans from mixtures of oral bacteria. The
aptured bacteria were stained to facilitate visualiza-
ion and proﬁlometry (Figure 1D). Alternatively, de-
ection or could be performed by using common op-
ical immunoassay methods, such as colorimetric,
uorescent, or chemiluminescent reporter mecha-
isms (Figure 1C). Accordingly, PDMS elastomer has
ound increased applications in the rapid prototyping
f microﬂuidic devices that incorporate optical detec-
ion. This modular methodology is applicable to other
ntibody-species pairs, and the translation of the assay
or use with oral ﬂuid is in progress.
Multidisciplinary efforts are under way to demon-
trate the diagnostic utility of saliva in a stand-alone
ral ﬂuid diagnostic chip [21]. Engineering hurdles
ust be traversed on the way to this goal. Particularly,
aliva is a very complex biomatrix that affects the u
B&MTnteraction between the sensor and the analyte. A
horough understanding of these phenomena is re-
uired in the development of robust biosensor tech-
ology. As with blood-based sensors, the goal of such
hrusts is to produce a portable point-of-care platform
apable of early detection of pathogens and markers of
isease onset. The added beneﬁt of noninvasive col-
ection of saliva simpliﬁes repeated sampling and
ould be tailored for rapid detection in ﬁeld hospitals
nd resource-poor settings.
oward the Realization of Cytomimicry through
iotic-Abiotic Interfacing
Toward the cytomimicry of processes observed in
ature, important studies have successfully used a syn-
hetic biology–based approach to support the func-
ionality of a wide array of membrane-bound proteins,
ncluding maltoporin and outer membrane protein F.
urthermore, the light-dependent ATP production
athway found in H. halobium has also been recreated
n these composite structures [22]. More recently, Ho
nd colleagues [10] demonstrated the ability to fabri-
ate large-area copolymer-protein ﬁlms integrated
ith microfabricated technology for transmembrane
rotein functionality studies to ﬁrmly establish these
ybrids as effective biocharacterization tools. More
mportantly, however, given that it has been well es-
ablished that triblock copolymers have served as ef-
ective replacements for cell membrane defects, these
obust protein-functionalized ﬁlms were also pre-
ented as possible implantable surface mimetics of
atural cell membranes with the added dimensions of
unctionality and complexity from the embedded pro-
eins. Langmuir-Blodgett ﬁlms of outer membrane
rotein F and copolymers of varying lengths were
eposited on solid substrates for protein characteriza-
ion. In addition, measurements of air-water interfa-
ial protein insertion demonstrated that the length of
he membrane structure used for protein reconstitu-
ion could be directly correlated with the efﬁciency of
rotein insertion. For example, lipid-based systems
xhibited the highest amounts of protein insertion and
ften resulted in protein-based surface pressure in-
reases in excess of 12 mN/m, whereas for the thickest
opolymer membranes (8 nm), the increases were of-
en approximately 6.9 mN/m. However, for the
horter copolymers (4 nm), protein-based surface
ressure changes were as high as 7.33 mN/m, thus
ndicating a higher insertion rate. This was explained
y the fact that membrane ﬂuidity and other proper-
ies, such as the ability to transport water across the
embrane and several other biomembrane-mimetic
roperties, are dependent on the membrane length. As
uch, the engineering of artiﬁcial membrane systems
ith thicknesses that more closely resemble those
ound in nature will play a critical role in the contin-
ed development of implantable biofunctional mate-
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9ials that possess inherent properties of natural cell
embranes.
To further demonstrate the concept of preserving
he functionality of biology within artiﬁcial mem-
ranes as well as enhancing the complexity of the
rocesses being harnessed, Ho et al. [23] coupled the
nergy-transducing behavior of the bacteriorhodopsin
nd cyclooxygenase proteins in a polymeric mem-
rane to produce a stand-alone light-dependent elec-
ron generator (Figure 2A). In this experiment, the
nput of light into a system where the primary com-
igure 1. Antibody immobilization to silicone elastomer for immu
hole immunoglobulin G (IgG) to PDMS by silanization with 3-a
ldehyde. B, Composite of atomic force microscope (AFM) scan
mmobilization (right). C, Schematic of the sandwich-type assay th
ptical proﬁlometer plot of S. mutans captured by the immobilizedonents were 2 bacterial proteins from independent t
6osts and a reconstitution polymeric matrix resulted in
he measurement of electron generation, a process
hat could not have been autonomously realized had
he proteins been evaluated individually. As such, this
oupled bioenergy transduction process could then be
iewed as a primitive derivation of higher-order be-
avior that is pervasive within biological membranes
nd is an important step toward the realization of
ytomimetic materials.
Bacteriorhodopsin was selected as a light-depen-
ent transmembrane proton gradient generator. Cy-
of oral pathogens. A, Proposed mechanism for amine coupling of
opyltriethoxysilane (APTS), followed by crosslinking with glutar-
ing the unmodiﬁed PDMS (left) and the PDMS after antibody
ld be performed on the PDMS sensors with optical detection. D,
ody. The bacteria have been stained to enhance contrast.noassay
minopr
s, show
at couochrome c oxidase was selected as the electron-gen-
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Brating species. In its native forward reaction,
ytochrome c oxidase serves as the last step of the
espiratory chain, whereby it receives an electron from
he cytochrome c mediator. This electron transport
echanism is coupled with a proton-pumping func-
ion of the protein. However, it was previously estab-
ished by Wikstrom and Morgan [24] that by intro-
ucing a high electron acceptor potential from the
ytochrome c mediator, as well as a high electrochem-
cal proton gradient (in this case, produced by bacte-
iorhodopsin), the activity of cytochrome c oxidase
rotein could be partially reversed. This would entail
hat the protons from the external gradient would
ravel back through the protein, and this process
ould be coupled with the transfer of electrons back
o the cytochrome c mediator. This work intended to
arvest those electrons for current measurement.
hrough the use of composite polymeric vesicles con-
aining both proteins that resided in a solution with a
igh concentration of cytochrome c, it was shown that
ight-induced current increases in excess of 10 A
ould be generated (Figure 2B). Demonstrating the
igure 2. Biofunctional nanomedical materials. A, Transmission
opolymeric vesicle (polymethyloxazoline [PMOXA]-PDMS-PMOX
hydrophobic core. This vesicle possesses a wide array of potential
, Resultant current generation from solution composite vesicles
lanar copolymer-protein ﬁlm that is directly interfaced with an a
ifferential nanogold-based staining patterns of substrates that cont
ompared with ﬁlms that do not contain protein (inset).oncept of cooperative protein activity from cytomi- s
B&MTetic materials speciﬁcally with respect to energy
ransduction, this study served as an example of using
synthetic biology approach to fabricate composite
olymeric vesicles that could process an input (light)
o produce outputs (current) that would not normally
e present if the system were deconstructed and each
omponent were analyzed individually. As such, the
omposite nanomachine composed of 3 components
bacteriorhodopsin, cytochrome c oxidase, and the
olymeric membrane) exhibited a basic form of com-
lex behavior to produce useful work.
Continued advancements in cytomimicry will
rive the fabrication of self-assembling protein-copol-
mer composites to simulate a wide array of biological
rocesses (Figure 2C and D). The ability to recreate
ertain phenomena through biotic-abiotic interfacing
ill then be expanded toward material implantation to
ddress various medical areas, including neuronal
amage and cardiac abnormalities. For example, the
bility to accurately pick and place nanoscale objects
ith continually progressing nanomanufacturing and
anipulation modalities, particularly, will enable
ron microscope image (original magniﬁcation, 100 000) of a
t contains a hydrophilic external and internal shell that sandwiches
tions, including drug carrying, protein coupling, and cytomimicry.
iorhodopsin/cyclooxygenase) measured by cyclic voltammetry. C,
substrate (e.g., glass and plastics) that sustains protein activity. D,
histidine–tagged proteins embedded within copolymer membraneselect
A) tha
applica
(bacter
biotic
ain 6toichiometric placement of proteins within the co-
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9olymers toward the generation of mimetic action
otentials. Current efforts to reconstitute sodium,
otassium, and chloride ion transporters will seek to
chieve the vision of using implantable, functionalized
embranes for neuromolecular medicine. With re-
pect to disorders of the cardiovascular system, con-
exins (Cx) have been well studied as molecular asso-
iates of arrhythmia and cardiomyopathy. These
roteins form gap junctions, or channels that permit
he transmembrane transport of ions and small mole-
ules between adjacent cells, and are critical for inter-
ellular communication. It has been widely established
hat different types of Cxs (e.g., Cx40, Cx43, and
x45) possess varying conductances and are spatially
istributed in deﬁned patterns across the regions of
he heart. The Cx43 protein is by far the most abun-
antly expressed Cx, and it has been observed that
x40 and Cx45 are expressed in specialized regions of
he heart. In fact, their distribution, among other
actors, is believed to contribute to the rhythm-gen-
rating and -preserving properties of different types of
yocytes in varying regions of the heart. Myocytes
ound in the cardiac impulse and conduction region
the sinoatrial node activates the atria and converges
n the atrioventricular node for distribution to the
entricles via the His bundle, main bundle branches to
ach ventricle, and Purkinje ﬁbers) contain a very
peciﬁc arrangement of Cx proteins that contribute to
ystemic cardiac impulse generation: this arrangement
iffers from that found in working myocytes of the
ardiac chambers [25]. For example, nodal myocytes
re typically smaller, with dispersed Cx proteins that
re associated with, in the case of the sinoatrial node,
he ability to activate the atrial tissue while resisting
yperpolarization [25]. In addition, this same distri-
ution enables a slowed conduction and sequential
trial and ventricular contraction. Given that the Pur-
inje ﬁbers serve as a distribution network for the
onduction pathway, associated myocytes contain
arge amounts of Cx40 and Cx43, which possess
igher conductances for this purpose. Furthermore,
x45, which possesses low conductance properties, is
ensely expressed in the conduction system to enable
aintenance of generated impulses [25].
The facilitation of proper cell-cell action potential
ransmission is regulated by ordered Cx distribution.
ardiac disorders such as arrhythmia and cardiomy-
pathy have been associated with alterations to these
istributions that disrupt the normal myocyte impulse
eneration and conduction properties. For example,
eductions in Cx43 levels have been correlated with
rrhythmia because of their vital role in sinoatrial
onduction. Furthermore, reduced Cx43 distribution
n ventricular myocytes has resulted in decreased con-
ractility. Integrating Cx40, Cx43, and Cx45 proteins
ith copolymeric materials is a potentially powerful
pproach to fabricating functional membranes that c
8an be coupled with emerging microsurgery tech-
iques for implantation into Cx-downexpressed re-
ions for reacquisition of normal activity. Envisioned
apabilities in picking and placing nanoscale objects
e.g., Cx proteins) will enable accurate distributional
ontrol of Cx proteins in these copolymer membranes.
n addition to these cardiomolecular therapeutic de-
ices, this approach will address a broad range of other
isorders, such as neuronal damage from spinal cord
njury, that may be alleviated through reacquisition of
iomolecular functionality. As such, these cytomi-
etic biomolecular therapeutics will signal a dramatic
hift toward the use of biology to derive engineering
aterials.
ONCLUSION
We have presented 2 devices that will contribute to
he realization of novel biosensing devices and biofunc-
ional materials as next-generation medical technologies.
hese systems include advanced devices for patient-side
iagnostics, as well as copolymers that have been func-
ionalized by membrane proteins to mimic cellular pro-
esses. These systems are envisioned to successfully
ridge the gap between foundational scientiﬁc progress
nd the realization of nanomedical devices with en-
anced capabilities (diagnostics) and higher-order be-
avior (materials).
With respect to advanced diagnostics, innovative
pplications of novel microfabrication and novel
anoengineering tools will enable scientists to manip-
late biological systems with unprecedented control.
hese emerging modalities, coupled with current
ultidisciplinary efforts to explore the use of saliva as
diagnostic biomatrix, for example, will seek to estab-
ish new boundaries in the development of biosensing
nd point-of-care systems. As such, the shrinking of
onventional laboratory processes will generate assays
hat accommodate smaller reagent volumes, shorter
rocessing times, and multiplexed sample analysis in a
ompact platform, thus further pushing the limits of
ab-on-a-chip performance.
Next-generation biofunctional nanomaterials
nd systems will not only serve as modalities for
tudying the molecular basis of abnormalities such
s cardiac arrhythmia and cardiomyopathy, but will
lso provide a cytomimetic approach to repairing
amaged cells and tissues by restoring normal func-
ionality. In addition, these devices will ﬁnd broad
pplicabilities in nanomedicine, including (1) the
se of concomitant protein functionality toward en-
rgy production and the powering of medical im-
lants, (2) the use of cytomimetic ﬁlms for cloaking,
nd (3) the enhancement of implant biocompatibil-
ty through reductions in immune response and
ellular encapsulation. Future efforts will expand
t
h
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Bhe dimensions of functionality possessed by these
ybrid copolymers to integrate immune-suppress-
ng components and a broader array of proteins to
nhance membrane cytomimetic properties and to
urther progress toward implantation studies and
pplications.
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